Tenax Therapeutics (TENX) News Today $0.27 -0.06 (-17.93%) (As of 12/29/2023 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineChapel Hill public company shrinks share volume by nearly 99%bizjournals.com - December 29 at 9:02 PMTenax Therapeutics (NASDAQ:TENX) Receives New Coverage from Analysts at StockNews.comamericanbankingnews.com - December 26 at 2:48 AMTenax Therapeutics Stock (NASDAQ:TENX) Dividends: History, Yield and Datesbenzinga.com - December 4 at 5:38 PMTENX: IND Clears Way for Phase IIIfinance.yahoo.com - November 20 at 3:11 PMTenax Therapeutics Announces Professor Javed Butler, M.D., M.P.H, M.B.A., joins PH-HFpEF Scientific Advisory Boardfinance.yahoo.com - November 17 at 1:11 PMWhy Is Tenax Therapeutics (TENX) Stock Up 300% Today?investorplace.com - November 13 at 5:02 PMTenax Therapeutics Shares Double Premarket After FDA Clears IND for TNX-103marketwatch.com - November 13 at 10:17 AMWhy Tenax Therapeutics (TENX) Stock Is Up 100%benzinga.com - November 13 at 10:17 AMTenax Therapeutics Announces FDA Clearance of IND for TNX-103 (oral levosimendan) for the Treatment of Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF), Initiation of Phase 3 sites expected 2023finance.yahoo.com - November 13 at 10:17 AMTenax Therapeutics Issued U.S. Patent for Oral Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)finance.yahoo.com - July 19 at 10:24 AMTENX - Tenax Therapeutics, Inc.finance.yahoo.com - July 13 at 9:40 AMTenax Therapeutics Achieves Major Milestone as USPTO Grants Notice of Allowance for U.S. Patent Application Covering Usetmcnet.com - May 31 at 10:27 AMTenax Therapeutics Achieves Major Milestone as USPTO Grants Notice of Allowance for U.S. Patent Application Covering Use of Oral Levosimendan (TNX-103) in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)finance.yahoo.com - May 31 at 10:27 AMTENX: Prioritizing Levosimendanfinance.yahoo.com - May 22 at 1:21 PMTenax Therapeutics Prioritizes Development Of TNX-103 For Heart Failurefinance.yahoo.com - April 12 at 6:36 PMTenax Therapeutics Provides 2023 Business Updatefinance.yahoo.com - April 12 at 1:05 PMTENX: Patents Guide the Wayfinance.yahoo.com - April 5 at 10:43 AMTENX Tenax Therapeutics, Inc.seekingalpha.com - March 31 at 3:41 PMTenax Announces Issuance of U.S. Patent Covering Use of IV Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)finance.yahoo.com - March 22 at 9:07 AMRoth MKM Initiates Coverage of Tenax Therapeutics (TENX) with Buy Recommendationmsn.com - March 8 at 5:49 PMAnalysts Offer Insights on Healthcare Companies: Abbott Labs (ABT), Tenax Therapeutics (TENX) and Day One Biopharmaceuticals (DAWN)markets.businessinsider.com - March 7 at 8:58 AMAnalysts Are Optimistic We'll See A Profit From Tenax Therapeutics, Inc. (NASDAQ:TENX)finance.yahoo.com - February 17 at 8:51 AMTENX: New Funding Puts Wind in the Sailsfinance.yahoo.com - February 15 at 1:47 PMTriangle pharma raising millions amid uncertain futurefinance.yahoo.com - February 7 at 2:01 PMTenax Therapeutics Down 20% After Offering Gets Pricedmarketwatch.com - February 3 at 2:26 PMTenax Therapeutics stock dips after pricing $15.6M securities offeringmsn.com - February 3 at 9:26 AMTenax Therapeutics Announces Pricing of Approximately $15.6 Million Public Offeringfinance.yahoo.com - February 3 at 9:26 AMTenax Therapeutics Shares Rise 73%, Co. Gets Patent for Hypertension Treatmentmarketwatch.com - February 2 at 3:21 PMWhy Tenax Therapeutics Shares Are Gaining Today?finance.yahoo.com - February 2 at 3:21 PMWhy Is Tenax Therapeutics (TENX) Stock Up 149% Today?investorplace.com - February 2 at 9:10 AMTenax Shares Double After Hours, Co. Gets Patent for Use of IV Levosimendan in PH-HFpEFmarketwatch.com - February 1 at 6:50 PMTenax Granted Notice of Allowance for U.S. Patent Application Covering Use of IV Levosimendan in Pulmonary Hypertensiontmcnet.com - February 1 at 6:50 PMTenax Granted Notice of Allowance for U.S. Patent Application Covering Use of IV Levosimendan in Pulmonary Hypertension with Heart Failure and Preserved Ejection Fraction (PH-HFpEF)finance.yahoo.com - February 1 at 6:50 PMTENX.OQ - | Stock Price & Latest News | Reutersreuters.com - January 25 at 2:34 PMTenax Therapeutics Shares Decline 18% On Plans to Offer Stocks, Warrantsmarketwatch.com - January 25 at 9:34 AMMorrisville firm takes action to avoid Nasdaq delisting amid potential salebizjournals.com - January 9 at 4:37 PMTenax Therapeutics Announces Reverse Stock Splitfinance.yahoo.com - January 4 at 11:59 AMTENX: Agility Required to Unlock Considerable Upsidefinance.yahoo.com - November 3 at 2:35 PMPositive Data Presented at HFSA Annual Meeting Demonstrate Effects of Oral Levosimendan in Patients with Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction (PH-HFpEF)finance.yahoo.com - October 10 at 8:57 AMWhy Oil-Related Stocks Traded Higher; Here Are 74 Biggest Movers From Yesterdaymsn.com - October 4 at 3:51 AMTenax Therapeutics to Explore Options, Including Sale >TENXmarketwatch.com - September 16 at 11:39 PMTenax Therapeutics Announces the Evaluation of Strategic Alternativesfinance.yahoo.com - September 15 at 8:46 AMmarketbeat.com - September 15 at 8:27 AMLoss-Making Tenax Therapeutics, Inc. (NASDAQ:TENX) Expected To Breakeven In The Medium-Termfinance.yahoo.com - August 28 at 2:44 PMTENX: The Pressure’s On: Awaiting Phase 3 Startfinance.yahoo.com - August 23 at 3:50 PMMorrisville pharma may consider sale with short cash runwaybizjournals.com - August 22 at 10:52 AMTenax Therapeutics Increuters.com - August 18 at 11:37 PMEpizyme + 20 Stocks Moving In Monday's Pre-Market Sessionbenzinga.com - June 27 at 6:57 AMTenax Therapeutics Inc - Stock Quote TENXmorningstar.com - June 14 at 10:43 PMMorrisville pharma raises $8M to target heart, lung diseasebizjournals.com - June 5 at 5:11 PM Get Tenax Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TENX and its competitors with MarketBeat's FREE daily newsletter. Email Address TENX Media Mentions By Week TENX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TENX News Sentiment▼0.290.84▲Average Medical News Sentiment TENX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TENX Articles This Week▼50▲TENX Articles Average Week Get Tenax Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TENX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Galera Therapeutics News Kazia Therapeutics News Guardion Health Sciences News Soligenix News Pulmatrix News Imunon News Atreca News Cadrenal Therapeutics News CNS Pharmaceuticals News Shuttle Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:TENX) was last updated on 12/31/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tenax Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.